查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049473

腸道疾病檢測市場規模、佔有率、趨勢和預測：按產品類型、檢測方法、疾病類型、最終用戶和地區分類，2026-2034 年

Enteric Disease Testing Market Size, Share, Trends and Forecast by Product Type, Technique, Disease Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球腸道疾病檢測市場規模為44億美元。展望未來，IMARC Group預測，該市場將在2026年至2034年間以2.84%的複合年成長率成長，到2034年達到57億美元。目前，亞太地區在該市場佔據主導地位，預計2025年將佔超過38.8%的市場。腸道疾病檢測市場佔有率的成長主要歸因於胃腸道感染疾病發病率的上升、人們對早期診斷意識的增強、診斷技術的進步、對更快更準確的檢測方法的需求不斷成長，以及全球對食品和飲用水安全標準的日益關注。

受胃腸道感染疾病和食物中毒病例增加以及診斷技術進步的推動，腸道傳染病檢查市場正快速成長。由細菌、病毒和寄生蟲引起的腸道感染疾病影響全球數百萬人，導致嚴重腹瀉、脫水和其他併發症。對快速、準確且經濟高效的診斷解決方案日益成長的需求正在推動市場擴張。食品安全意識的提高、政府對疾病監測的重視以及PCR和免疫檢測等分子診斷技術的進步，都促進了對診斷設備製造商的需求。在醫療領域技術進步的支持下，這些公司開始大力投資研發更快、更可靠的檢測解決方案。檢查室自動化程度的提高和就地檢驗試劑盒的普及也推動了市場成長。此外，研究機構和醫療機構之間的合作使診斷產品更容易取得和使用。同時，對早期準確診斷的需求不斷成長，持續影響腸道傳染病檢查市場的趨勢，而早期準確診斷是控制和預防疫情爆發的關鍵因素。

受食物中毒感染疾病以及診斷技術進步的推動，美國正崛起為腸道傳染病檢查的主要區域市場。分子診斷技術，包括聚合酶鍊式反應（PCR）和免疫檢測，因其高準確性和快速出結果而日益普及。政府主導的舉措，例如美國食品藥物管理局（FDA）的《食品安全現代化法案》（FSMA），透過強調預防措施和早期檢測，進一步推動了市場需求。醫院、診斷檢查室和就地檢驗機構是診斷自動化和人工智慧驅動的效率提升的關鍵終端使用者。美國市場的領導企業正大力投資研發，以期將尖端且價格合理的檢測解決方案推向市場。預計未來幾年，不斷上漲的醫療保健成本和日益嚴格的食品安全標準也將推動美國腸道傳染病檢查市場的擴張。

腸道傳染病檢查市場的發展趨勢：

胃腸道感染疾病發生率增加

衛生條件差、食物和水受到污染，以及人口密度極高（尤其是在發展中地區），導致胃腸道疾病發生率上升，對腸道傳染病檢查的需求也隨之增加。根據《印度時報》2024年的一篇報導，由於水源污染和衛生條件差，班加羅爾的胃腸道疾病病例正在增加。雖然生病時應避免飲用牛奶，但對於因腹瀉而有脫水風險的兒童來說，口服補液鹽（ORS）至關重要。根據世界衛生組織統計，光是腹瀉一項就導致全球約150萬人死亡。在開發中國家，五歲以下兒童尤其容易腹瀉、嘔吐、死亡和營養不良。這顯著提升了腸道傳染病檢查市場的價值。

政府和監管措施

隨著各國政府和衛生組織實施嚴格的食品和飲用水安全標準並增加對公共衛生基礎設施的投入，相關基礎設施正在不斷改善。這進一步推動了市場發展，因為人們越來越需要頻繁且有效的腸道傳染病檢查來預防疫情爆發，並確保公眾安全。例如，2024年4月，印度食品安全標準局（FSSAI）與德里食品安全局合作，針對大都會區的主要市場發起了一項大規模的意識提升宣傳活動。同樣，莫迪政府的另一項重要計畫——國家衛生任務（NHM）也致力於發展基層醫療基礎設施、基本藥物和診斷技術，以及提升人力資源能力。所有這些措施都旨在減少患者到居住地區尋求昂貴治療的需求，從而推動未來幾年腸道傳染病檢查市場的成長。

診斷技術取得了重大進展

聚合酵素鏈鎖反應(PCR) 和次世代定序(NGS) 等分子診斷技術的進步，使得快速、準確、徹底地檢測腸道感染疾病成為可能。市場正在迅速擴張。例如，2023 年 8 月，ArcticZymes Technologies (AZT) 發表了一款新產品－AZtaq™ DNA聚合酵素。 AZtaq™ 是一種高品質、耐熱的 DNA聚合酵素，可用於聚合酵素鏈鎖反應(PCR) 應用。該公司推出 AZtaq™ 是對其分子儀器產品線的合理補充。這種耐熱 DNA聚合酵素是 PCR 中的關鍵酶，可用於多種分子診斷和研究應用。這進一步推動了全球腸道傳染病檢查市場的收入成長。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球腸道疾病檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 試劑和耗材
  • 裝置

第7章 市場區隔：依方法

  • 分子診斷
  • 免疫診斷

第8章 市場區隔：依疾病類型分類

  • 細菌性腸道疾病
    • 主要類型
      • 艱難梭菌
      • 曲狀桿菌感染
      • 霍亂
      • 大腸桿菌
      • 幽門螺旋桿菌
      • 沙門氏菌病
      • 痢
  • 病毒性腸疾病
    • 主要類型
      • 輪狀病毒
      • 諾羅病毒
      • 其他
  • 寄生蟲性腸道疾病
    • 主要類型
      • 阿米巴病
      • 隱孢子蟲病
      • 賈第蟲病

第9章 市場區隔：依最終用戶分類

  • 醫院診斷檢查室
  • 獨立診斷實驗室
  • 學術研究機構
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • BD（Becton, Dickinson and Company）
    • Bio-Rad Laboratories Inc.
    • Biomerica Inc.
    • Biomerieux SA
    • Cepheid Inc.（Danaher Corporation）
    • Coris BioConcept
    • DiaSorin
    • Meridian Bioscience Inc.
    • Quest Diagnostics
Product Code: SR112026A2544

The global enteric disease testing market size was valued at USD 4.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 5.7 Billion by 2034, exhibiting a CAGR of 2.84% from 2026-2034. Asia Pacific currently dominates the market, holding a market share of over 38.8% in 2025. The enteric disease testing market share is growing due to the increasing incidence of gastrointestinal infections, growing awareness for early diagnosis, advancement in diagnostic technologies, rising demand for faster and accurate testing methods, and increasing global concern for food and water safety standards.

The enteric disease testing market growth is increasing due to the rise of gastrointestinal infections and foodborne diseases and the development of diagnostic technologies. Enteric diseases, caused by bacteria, viruses, and parasites, affect millions worldwide, thereby causing severe diarrhea, dehydration, and other complications. The growth in demand for rapid, accurate, and cost-effective diagnostic solutions is fueling the expansion of the market. Growing awareness about food safety and government initiatives toward disease surveillance coupled with molecular diagnostics such as PCR and immunoassays propel the demand of diagnostic companies, which have begun to invest heavily in faster, more reliable, and quick test solutions, aided by technological upgradation in the healthcare sector. The drive for automation in the laboratory, together with point-of-care testing kits, propels the market ahead. Furthermore, partnerships between research centers and healthcare institutions are making diagnostic products more accessible and available. In addition, increased demand for early and accurate diagnosis will continue to influence the enteric disease testing market trends, an important factor in controlling and preventing outbreaks.

The United States has emerged as a key regional market for enteric disease testing, driven by the increasing cases of foodborne diseases, awareness about gastrointestinal infections, and advances in diagnostic technologies. Molecular diagnostics, which include PCR and immunoassays, are gaining popularity as they are precise and deliver fast results. Government initiatives, for instance, the FDA's Food Safety Modernization Act (FSMA), are further boosting market demand by emphasizing preventive measures and early detection. Hospitals, diagnostic laboratories, and point-of-care testing facilities are major end-users of efficiency through automation and AI in diagnostics. Leading companies in the US market are making significant R&D investments to launch cutting-edge, reasonably priced testing solutions. The cost of health care and the stringency in food safety standards are also expected to increase the U.S. enteric disease testing market over the next few years.

ENTERIC DISEASE TESTING MARKET TRENDS:

Rising Incidence of Gastrointestinal Infections

With the increasing incidence of gastrointestinal diseases due to lack of sanitation, contaminated food, and water, and the alarmingly high population density, mostly in developing regions, the enteric disease testing demand is increasing. Bengaluru has witnessed a rise in gastrointestinal diseases due to tainted water sources and inadequate sanitation, according to a 2024 Times of India story. While milk should be avoided during illnesses, ORS is essential for children who are in danger of dehydration from diarrhea. According to the WHO, about 1.5 Million people die worldwide due to diarrheal disease alone. Children less than 5 years old in developing countries are being especially struck with diarrhea, vomiting, deaths, and malnutrition. This is further increasing the value of the enteric disease testing market substantially.

Government and regulatory activities

Increasing public health infrastructure is growing as the government and health organizations are introducing stringent food and water safety standards and investing in public health infrastructure. This is further fueling the requirement for frequent and effective enteric disease testing to prevent outbreaks and safeguard the public, which is further boosting the market. For instance, the Food Safety and Standards Authority of India (FSSAI) launched a massive awareness and sensitization campaign in April 2024, that covered key markets in the national capital, in association with the Food Safety Department, Delhi. Likewise, the NHM is another flagship program under the Modi government, which deals with the development of health infrastructure, essential drugs and diagnostics, and human resource capabilities at the grassroots level. All these have been aimed at reducing the patient's need for expensive treatments outside their localities, which in turn is enhancing the enteric disease testing market forecast over the coming years.

Significant advancements in diagnostic technologies

Enteric infections may now be detected quickly, accurately, and thoroughly due to advancements in molecular diagnostics such as polymerase chain reaction (PCR) and next-generation sequencing (NGS). The market is expanding more quickly. For instance, ArcticZymes Technologies (AZT) unveiled AZtaqTM DNA Polymerase, a novel product, in August 2023. A premium thermostable DNA polymerase that may be used in polymerase chain reaction (PCR) applications is called AZtaqTM. introduced the AZtaqTM, a logical addition to the business's line of molecular instruments. The thermostable DNA polymerase is a crucial enzyme in PCR that makes many molecular diagnostic and research applications possible. This is further driving the enteric disease testing market revenue across the globe.

ENTERIC DISEASE TESTING INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Reagents and Consumables
  • Equipment

The demand for the reagents and consumables was driven by its need for accurately and efficiently operating diagnostic processes. Repeated testings for pathogens in the gut requires constant stock replenishment for high-quality reagents and consumables. More importantly, rising infectious disease levels and advancements in molecular and rapid testing methods lead to the application of specialized consumables. Increasing governmental grants and the establishment of health infrastructures further promote demand for these core testing supplies. Technological upgrades in the machinery of diagnostic systems, for instance, automated PCR systems, as well as platforms for next-generation sequencing, drive further equipment demands in the market report on enteric disease testing. There is a necessity for high-throughput, reliable, and accurate diagnosis, thereby resulting in an acceptance of highly developed equipment. Additional factors of growing demand include extensive investments in the development of healthcare infrastructure, especially in up-and-coming markets, and investments in laboratory modernization. Additionally, improved disease surveillance programs and public health initiatives boost the market for diagnostic equipment.

Analysis by Technique:

  • Molecular Diagnostics
  • Immunodiagnostics

Molecular diagnostics techniques hold the leading position in the market fueled by their high accuracy, sensitivity, and faster turnaround times. These techniques, for example, PCR and next-generation sequencing, permit the accurate detection of a diverse range of pathogens, thus further enhancing disease control and outbreak response. For example, Roche announced the launching of the LightCycler(R) PRO System in November 2023, building on the established gold standard technology of the previous LightCycler(R) Systems. This system is designed to increase performance and usability requirements while connecting translational research with in vitro diagnostics. The LightCycler PRO System further enhances Roche's molecular PCR testing portfolio, which features solutions for different practitioners, from conducting research to testing patients who suffer from cancer, infectious diseases, and many more public health challenges. This is further propelling the demand for enteric disease testing globally.

Analysis by Disease Type:

  • Bacterial Enteric Disease
    • C. Difficile
    • Campylobacteriosis
    • Cholera
    • E. Coli
    • H. Pylori
    • Salmonellosis
    • Shigellosis
  • Viral Enteric Disease
    • Rotavirus
    • Norovirus
    • Others
  • Parasitic Enteric Disease
    • Amebiasis
    • Cryptosporidiosis
    • Giardiasis

Bacterial enteric diseases represent the largest segment with a share of 48.0%. The high prevalence of infections such as C. difficile, E. coli, and Salmonellosis creates a significant public health risk and drives the demand for enteric disease testing in bacterial types. Rapid, accurate diagnostics are important for effective treatment, outbreak management, and infection control. Testing demand is also fueled by the association of H. pylori with severe gastrointestinal conditions. The increasing foodborne and waterborne outbreaks, stringent food safety regulations, and the need for efficient healthcare interventions further boost the market for bacterial enteric disease testing.

Analysis by End User:

  • Hospital Diagnostic Laboratories
  • Independent Diagnostic Laboratories
  • Academic and Research Institutes

In the hospital diagnostic laboratory, the need for enteric disease testing arises from the urgent necessity for an accurate diagnosis so that proper patient management and treatment can be assured. High patient volumes and the critical nature of diagnosing gastrointestinal infections require reliable and efficient testing protocols. Independent diagnostic laboratories are in demand due to their specialized services and ability to provide rapid, high-volume testing. They are crucial for routine screening, outbreak management, and offering advanced diagnostic techniques, thus meeting the needs of both healthcare providers and patients. This further creates a positive enteric disease testing market outlook. There is a growing concern in academic and research institutes to study enteric pathogens, develop novel detection techniques, and perform epidemiological research, thereby creating an increased demand. Besides, more funds and grants to infectious disease research organizations increase the demand for high-quality and accurate testing capabilities to support scientific activities and public health.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Asia Pacific accounted for a large share of 38.8% for the enteric disease testing market, driven by the increasing incidence rates of gastrointestinal infections due to poor sanitation and hygiene. Rotavirus , Cryptosporidium spp., enterotoxigenic Escherichia coli (ETEC), and Shigella spp. are the primary causes of diarrheal illnesses and deaths, according to new data from the Global Enteric Multicenter Study (GEMS) on the burden and etiology of diarrhea among children living in developing nations. Moreover, norovirus infections, which equally affect adults and children, are the primary source of foodborne disease outbreaks and are responsible for 20% of diarrheal diseases. Consequently, rising awareness about health problems, increasing government efforts in controlling diseases, and better health infrastructure also spur demand. Improved diagnostics and an increased incidence of food and water-borne diseases fuel the growth of the market further. Rapid urbanization and the expanding middle-class population base, with greater access to healthcare, are contributing to the market growth.

The market for North American enteric disease testing is stimulated by strong healthcare infrastructure, advanced diagnostic technologies, and stringent food safety regulations. The CDC and the FDA play a crucial role in disease surveillance and prevention, enforcing strict food and water safety standards. Saliently, the staggering prevalence rates of foodborne illnesses, including Salmonella and Norovirus, drive demand for quick diagnostics. Molecular diagnostics, automation, and AI-based testing are revolutionizing the market. Increased R&D investment along with initiatives of the FDA, such as FSMA, are factors broadening the market's expansion.

The enteric disease testing market in Europe is also expected to grow through stringent food safety laws of the EFSA and rapidly increasing foodborne illness outbreaks. High usage of molecular diagnostics and point-of-care testing is driving the growth of the market. Countries like Germany, the UK, and France are highly investing in diagnostic innovations, improving the efficiency of testing. With the increasing organic and processed food demand, the concern over contamination has increased the demand for rapid and high throughput testing solutions across clinical and food safety sectors.

The Latin American enteric disease testing market is growing due to the rise in foodborne illness cases and the increase in healthcare investments. Poor sanitation conditions and limited water availability are commonly found in numerous regions, increasing the risk for frequent outbreaks due to cholera, E. coli, or rotavirus infection. Governments undertake public health projects, enhance regulatory food safety, and strengthen disease surveillance. Moreover, the growth in private diagnostic laboratory facilities and more affordable rapid-testing kits is creating an opportunity in enteric disease diagnostics, more so in such countries as Brazil, Mexico, and Argentina, as their healthcare is rapidly changing.

In the Middle East and Africa, enteric disease testing demand is increasing due to a high burden of waterborne and foodborne illnesses linked to poor sanitation, contaminated water, and inadequate healthcare access. Diarrheal diseases are a leading cause of mortality, especially in children. Governments and international organizations are focusing on improving disease detection through public health programs and expanded laboratory networks. Growing urbanization, increasing food imports, and significant investments in the healthcare infrastructure further fuel the utilization of modern diagnostic techniques, primarily in Saudi Arabia, South Africa, and the UAE.

KEY REGIONAL TAKEAWAYS:

UNITED STATES ENTERIC DISEASE TESTING MARKET ANALYSIS

In 2025, the United States held a share of 90.0% of the enteric disease testing market in North America due to emerging outbreaks of foodborne illnesses, a strict regulatory framework, and consumer awareness. According to the Centers for Disease Control and Prevention, millions of infections are produced annually due to foodborne pathogens like Salmonella, E. coli, and Norovirus, and therefore there is a need for sophisticated diagnostic solutions. According to the CDC, each year about 1 in 6 Americans (or 48 Million people) gets sick, 128,000 are hospitalized, and 3,000 die of foodborne diseases. Moreover, the FDA and the USDA have made strict compliance with food safety regulations, and the demand for rapid, accurate testing technologies, including PCR-based and immunoassay methods, is rising. In addition to this, multiplex molecular diagnostics are adopted in increasing numbers with the possibility of detecting more than one pathogen simultaneously at a high specificity. Technology advances, like NGS, improve the identification of pathogens, especially in surveillance and outbreak management. Point-of-care testing is expanding with improvements in early detection in healthcare settings and remote locations. Further, the increasing emergence of antimicrobial-resistant bacteria is motivating more investment in new diagnostic platforms and promoting private-public partnerships between companies, research organizations, and government agencies. Higher healthcare expenditure and insurance coverage for diagnostic testing facilitate early screening and thus contribute to market growth. Additionally, the growing demand for at-home test kits due to e-commerce expansion is shaping the market landscape.

EUROPE ENTERIC DISEASE TESTING MARKET ANALYSIS

Europe's enteric disease testing market is driven by stringent food safety laws, technological advancements, and high public health awareness. The European Food Safety Authority has strict regulations over microbial contamination in food and water, forcing manufacturers and healthcare facilities to employ rapid and reliable diagnostic methods. The increased surveillance of zoonotic diseases and antimicrobial resistance has led to a surge in demand for advanced molecular and immunological testing platforms. Salmonella was the causative agent linked to the highest multi-country foodborne outbreaks reported in the European Union in 2023, at 17 foodborne outbreaks, 81.0% of the total for multi-country foodborne outbreaks, according to the European Union One Health 2023 Zoonoses report. Besides this, the region is experiencing tremendous growth in automated laboratory systems and next-generation sequencing (NGS) techniques, allowing for the accurate identification of enteric pathogens. The increasing number of foodborne infections due to imported food products has enhanced the demand for real-time PCR and multiplex diagnostic assays. Public-private partnerships and European Union-funded projects are promoting research into innovative diagnostic solutions, which in turn is further fueling the growth of the market. Additionally, the growing incidence of traveler's diarrhea, especially due to tourism within and outside the region, is enhancing the demand for portable and rapid testing solutions. In addition, advancing point-of-care diagnostics, integrated with AI-driven data analytics for tracking the disease, also enhances the efficiency of outbreak responses. The market also contributes to the rising integration of diagnostic labs with digital health platforms, improving test access and turnaround time.

ASIA PACIFIC ENTERIC DISEASE TESTING MARKET ANALYSIS

Asia Pacific's enteric disease testing market is being propelled by increasing disease burden, rapid urbanization, and improvements in healthcare infrastructure. The region experiences high rates of waterborne and foodborne infections on account of inadequate sanitation and contaminated drinking water. According to studies, an estimated 37.7 Million Indians suffer from waterborne illnesses each year. Salmonella, Vibrio cholerae, rotavirus, and Shigella are still among the major pathogens, and thus, governing agencies are taking measures to strengthen surveillance programs and invest in advanced diagnostic technologies. In addition to this, increasing investments in healthcare, especially in China, India, and Southeast Asian countries, are helping the adoption of automated diagnostic systems for enteric pathogens. The growth rate of the market is being fueled by increasing private laboratories and multinational diagnostic companies, as the PCR-based, ELISA, and microarray platforms are also becoming popular, as they show high accuracy along with rapid results. In addition, technological progress in molecular diagnostics and increased point-of-care testing are making faster and more accurate detection possible. Favorable government initiatives, including India's National Health Mission and China's CDC initiatives, will encourage routine screening. The rising incidence of antimicrobial resistance and emerging zoonotic pathogens are also motivating the development of rapid diagnostic tools, especially in the context of food safety regulations and outbreak response mechanisms.

LATIN AMERICA ENTERIC DISEASE TESTING MARKET ANALYSIS

Latin America's enteric disease testing market is growing owing to frequent waterborne disease outbreaks, improving healthcare infrastructure, and rising government initiatives. Many countries face challenges with unsafe drinking water and inadequate sanitation, leading to high incidence rates of cholera, Shigella, and rotavirus infections. There were around 24,200 suspected cholera cases as of 17 January 2023, as reported in the Latin America & The Caribbean Weekly Situation Update. The region's governing agencies are largely increasing investments in surveillance programs and expanding diagnostic capacities, especially in Brazil, Mexico, and Argentina. In addition, emerging private diagnostic laboratories and collaborations with major global diagnostic firms continue to improve testing availability. Point-of-care and rapid molecular testing technologies are becoming more prevalent, especially in outlying and less privileged regions. Further demand for dependable diagnostic solutions is coming from further strengthened regulations related to food and beverage safety along with increased awareness about antimicrobial resistance. The expansion of public health insurance programs and international funding of infectious disease control are also in support of this market growth.

MIDDLE EAST AND AFRICA ENTERIC DISEASE TESTING MARKET ANALYSIS

The Middle East and Africa's enteric disease testing market is growing due to high disease prevalence, increasing government healthcare spending, and improvements in diagnostic capabilities. Reports indicate that the healthcare expenditure in the Gulf Cooperation Council (GCC) is estimated to be at USD 135.5 Billion by 2027. Water contamination, poor sanitation, and climate-related factors contribute to persistent outbreaks of Cholera, Typhoid fever, and Norovirus. Governments and non-governmental organizations (NGOs) are intensifying efforts to improve water quality and expand disease surveillance programs. Moreover, the adoption of rapid diagnostic kits, particularly in regions with limited laboratory infrastructure, is enhancing early disease detection. Investments in centralized laboratory networks and mobile diagnostic units are improving accessibility in remote areas. In addition to the above, with isothermal amplification-based tests, the advantage of cost and reliability in resource-poor environments is making such technologies more relevant. International partnerships with WHO and UNICEF for infectious diseases are also fueling the need for efficient solutions in enteric disease testing.

COMPETITIVE LANDSCAPE:

The competition in the market for enteric disease testing is highly competitive, wherein the key market players are concentrated on technological advances, strategic collaboration, and geographically expanding markets to strengthen market presence. Major companies such as bioMerieux, Thermo Fisher Scientific, BD, and Abbott are investing heavily in molecular diagnostics, automation, and AI-driven solutions to improve test accuracy and efficiency. One of the significant trends is the development of rapid and point-of-care testing kits, which allows quicker diagnosis and treatment, especially in resource-limited settings. Companies are also integrating next-generation sequencing (NGS) and PCR-based diagnostics to enhance detection capabilities. The market is being shaped by strategic mergers and acquisitions, such as partnerships between diagnostic firms and government agencies to improve disease surveillance. Increasing focus on sustainability and affordability is driving innovation in cost-effective diagnostic solutions, making it more accessible in emerging markets. These efforts are creating a positive enteric disease testing market outlook.

The report provides a comprehensive analysis of the competitive landscape in the enteric disease testing market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • BD (Becton, Dickinson and Company)
  • Bio-Rad Laboratories Inc.
  • Biomerica Inc.
  • Biomerieux SA
  • Cepheid Inc. (Danaher Corporation)
  • Coris BioConcept
  • DiaSorin
  • Meridian Bioscience Inc.
  • Quest Diagnostics

Key Questions Answered in This Report

1. How big is the enteric disease testing market?

2. What is the future outlook of enteric disease testing market?

3. What are the key factors driving the enteric disease testing market?

4. Which region accounts for the largest enteric disease testing market share?

5. Which are the leading companies in the global enteric disease testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Enteric Disease Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technique

  • 7.1 Molecular Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Immunodiagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Disease Type

  • 8.1 Bacterial Enteric Disease
    • 8.1.1 Market Trends
    • 8.1.2 Major Types
      • 8.1.2.1 C. Difficile
      • 8.1.2.2 Campylobacteriosis
      • 8.1.2.3 Cholera
      • 8.1.2.4 E. Coli
      • 8.1.2.5 H. Pylori
      • 8.1.2.6 Salmonellosis
      • 8.1.2.7 Shigellosis
    • 8.1.3 Market Forecast
  • 8.2 Viral Enteric Disease
    • 8.2.1 Market Trends
    • 8.2.2 Major Types
      • 8.2.2.1 Rotavirus
      • 8.2.2.2 Norovirus
      • 8.2.2.3 Others
    • 8.2.3 Market Forecast
  • 8.3 Parasitic Enteric Disease
    • 8.3.1 Market Trends
    • 8.3.2 Major Types
      • 8.3.2.1 Amebiasis
      • 8.3.2.2 Cryptosporidiosis
      • 8.3.2.3 Giardiasis
    • 8.3.3 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospital Diagnostic Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Independent Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Academic and Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 BD (Becton, Dickinson and Company)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bio-Rad Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerica Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Biomerieux SA
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Cepheid Inc. (Danaher Corporation)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Coris BioConcept
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 DiaSorin
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Meridian Bioscience Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quest Diagnostics
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Enteric Disease Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Enteric Disease Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Enteric Disease Testing Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Enteric Disease Testing Market: Breakup by Technique (in %), 2025
  • Figure 5: Global: Enteric Disease Testing Market: Breakup by Disease Type (in %), 2025
  • Figure 6: Global: Enteric Disease Testing Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Enteric Disease Testing Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Enteric Disease Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Enteric Disease Testing (Reagents and Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Enteric Disease Testing (Reagents and Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Enteric Disease Testing (Equipment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Enteric Disease Testing (Equipment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Enteric Disease Testing (Molecular Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Enteric Disease Testing (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Enteric Disease Testing (Immunodiagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Enteric Disease Testing (Immunodiagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Enteric Disease Testing (Bacterial Enteric Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Enteric Disease Testing (Viral Enteric Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Enteric Disease Testing (Viral Enteric Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Enteric Disease Testing (Parasitic Enteric Disease) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Enteric Disease Testing (Hospital Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Enteric Disease Testing (Independent Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Enteric Disease Testing (Academic and Research Institutes) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Enteric Disease Testing (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Enteric Disease Testing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Enteric Disease Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: North America: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: North America: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: United States: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: United States: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Canada: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Canada: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Asia Pacific: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Asia Pacific: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: China: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: China: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Japan: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Japan: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: India: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: India: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: South Korea: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: South Korea: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Australia: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Australia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Indonesia: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Indonesia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Europe: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Europe: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Germany: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Germany: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: France: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: France: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: United Kingdom: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: United Kingdom: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Italy: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Italy: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Spain: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Spain: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Russia: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Russia: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Latin America: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Latin America: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Brazil: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Brazil: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Mexico: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Mexico: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Others: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Others: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Middle East and Africa: Enteric Disease Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Middle East and Africa: Enteric Disease Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Global: Enteric Disease Testing Industry: SWOT Analysis
  • Figure 80: Global: Enteric Disease Testing Industry: Value Chain Analysis
  • Figure 81: Global: Enteric Disease Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Enteric Disease Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Enteric Disease Testing Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Enteric Disease Testing Market Forecast: Breakup by Technique (in Million USD), 2026-2034
  • Table 4: Global: Enteric Disease Testing Market Forecast: Breakup by Disease Type (in Million USD), 2026-2034
  • Table 5: Global: Enteric Disease Testing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Enteric Disease Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Enteric Disease Testing Market Structure
  • Table 8: Global: Enteric Disease Testing Market: Key Players